Organizing pneumonia associated with rituximab: Challenges raised by establishing causality.
Lioté
Huguette
H
D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000009:adverse effects*; D015984:Causality; D006801:Humans; D007155:Immunologic Factors / Q000009:adverse effects*; D011014:Pneumonia / Q000139:chemically induced* / Q000453:epidemiology / Q000503:physiopathology; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D007155:Immunologic Factors; D000069283:Rituximab